Published in Proc Natl Acad Sci U S A on August 03, 1999
Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1. Br J Pharmacol (2012) 1.64
Analysis of the PC12 cell transcriptome after differentiation with pituitary adenylate cyclase-activating polypeptide (PACAP). J Neurochem (2002) 1.09
Impaired nerve regeneration and enhanced neuroinflammatory response in mice lacking pituitary adenylyl cyclase activating peptide. Neuroscience (2007) 1.06
PACAP-38 induces neuronal differentiation of human SH-SY5Y neuroblastoma cells via cAMP-mediated activation of ERK and p38 MAP kinases. J Neurochem (2007) 1.01
Signaling through the neuropeptide GPCR PAC₁ induces neuritogenesis via a single linear cAMP- and ERK-dependent pathway using a novel cAMP sensor. FASEB J (2012) 0.98
Pituitary adenylate cyclase-activating polypeptide protects rat cerebellar granule neurons against ethanol-induced apoptotic cell death. Proc Natl Acad Sci U S A (2002) 0.96
Altered ATP7A expression and other compensatory responses in a murine model of Menkes disease. Neurobiol Dis (2007) 0.95
The neuroprotective effect of pituitary adenylate cyclase-activating polypeptide on cerebellar granule cells is mediated through inhibition of the CED3-related cysteine protease caspase-3/CPP32. Proc Natl Acad Sci U S A (2000) 0.92
Pituitary adenylyl cyclase activating polypeptide inhibits gli1 gene expression and proliferation in primary medulloblastoma derived tumorsphere cultures. BMC Cancer (2010) 0.90
PACAP type I receptor transactivation is essential for IGF-1 receptor signalling and antiapoptotic activity in neurons. EMBO J (2007) 0.90
Endogenous PACAP acts as a stress response peptide to protect cerebellar neurons from ethanol or oxidative insult. Peptides (2005) 0.88
Pituitary adenylate cyclase-activating polypeptide prevents the effects of ceramides on migration, neurite outgrowth, and cytoskeleton remodeling. Proc Natl Acad Sci U S A (2005) 0.86
PACAP is present in the olfactory system and evokes calcium transients in olfactory receptor neurons. J Neurophysiol (2003) 0.84
Lot1 is a key element of the pituitary adenylate cyclase-activating polypeptide (PACAP)/cyclic AMP pathway that negatively regulates neuronal precursor proliferation. J Biol Chem (2009) 0.84
PACAP-induced ERK activation in HEK cells expressing PAC1 receptors involves both receptor internalization and PKC signaling. Am J Physiol Cell Physiol (2014) 0.83
Long-Term Estrogen Receptor Beta Agonist Treatment Modifies the Hippocampal Transcriptome in Middle-Aged Ovariectomized Rats. Front Cell Neurosci (2016) 0.78
Buyang Huanwu decoction increases the expression of glutamate transporter-1 and glutamate synthetase in association with PACAP-38 following focal ischemia. Biomed Rep (2015) 0.77
Pituitary adenylyl cyclase-activating peptide counteracts hedgehog-dependent motor neuron production in mouse embryonic stem cell cultures. J Neurosci Res (2011) 0.76
Activation of PAC1 Receptors in Rat Cerebellar Granule Cells Stimulates Both Calcium Mobilization from Intracellular Stores and Calcium Influx through N-Type Calcium Channels. Front Endocrinol (Lausanne) (2013) 0.76
Microarray analysis of bone marrow lesions in osteoarthritis demonstrates upregulation of genes implicated in osteochondral turnover, neurogenesis and inflammation. Ann Rheum Dis (2017) 0.75
PACAP modulation of calcium ion activity in developing granule cells of the neonatal mouse olfactory bulb. J Neurophysiol (2014) 0.75
Neuroblast migration and P2Y(1) receptor mediated calcium signalling depend on 9-O-acetyl GD3 ganglioside. ASN Neuro (2012) 0.75
Programmed cell death and the control of cell survival: lessons from the nervous system. Science (1993) 4.63
Neuron-glia relationship during granule cell migration in developing cerebellar cortex. A Golgi and electronmicroscopic study in Macacus Rhesus. J Comp Neurol (1971) 3.54
Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun (1989) 3.03
Postnatal development of the cerebellar cortex in the rat. 3. Maturation of the components of the granular layer. J Comp Neurol (1972) 2.13
Diverse migratory pathways in the developing cerebral cortex. Science (1992) 1.83
Motility and cytoskeletal organization of migrating cerebellar granule neurons. J Neurosci (1995) 1.73
The role of depolarization in the survival and differentiation of cerebellar granule cells in culture. J Neurosci (1987) 1.69
Pituitary adenylate cyclase-activating polypeptide (PACAP-38) protects cerebellar granule neurons from apoptosis by activating the mitogen-activated protein kinase (MAP kinase) pathway. J Neurosci (1997) 1.58
In situ labeling of granule cells for apoptosis-associated DNA fragmentation reveals different mechanisms of cell loss in developing cerebellum. Neuron (1993) 1.58
Distinct modes of neuronal migration in different domains of developing cerebellar cortex. J Neurosci (1998) 1.43
Staggerer, a new mutation in the mouse affecting the cerebellum. Science (1962) 1.33
Neuronal differentiation rescued by implantation of Weaver granule cell precursors into wild-type cerebellar cortex. Science (1993) 1.30
Cerebellar granule cell neurogenesis is regulated by cell-cell interactions in vitro. Neuron (1991) 1.27
The 38-amino acid form of pituitary adenylate cyclase-activating polypeptide stimulates dual signaling cascades in PC12 cells and promotes neurite outgrowth. J Biol Chem (1992) 1.26
Local control of granule cell generation by cerebellar Purkinje cells. Mol Cell Neurosci (1995) 1.21
Pituitary adenylate cyclase-activating polypeptide is an autocrine inhibitor of mitosis in cultured cortical precursor cells. Proc Natl Acad Sci U S A (1997) 1.20
Pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors: neuroendocrine and endocrine interaction. Front Neuroendocrinol (1995) 1.16
Migration patterns of clonally related granule cells and their progenitors in the developing chick cerebellum. Neuron (1994) 1.09
Pituitary adenylate cyclase activating polypeptide prevents apoptosis in cultured cerebellar granule neurons. Mol Pharmacol (1996) 1.09
Pituitary adenylate cyclase-activating polypeptide promotes cell survival and neurite outgrowth in rat cerebellar neuroblasts. Neuroscience (1997) 1.06
PACAP type I receptor activation promotes cerebellar neuron survival through the cAMP/PKA signaling pathway. DNA Cell Biol (1997) 1.05
Distribution of the mRNA for a pituitary adenylate cyclase-activating polypeptide receptor in the rat brain: an in situ hybridization study. J Comp Neurol (1996) 1.05
Interaction of granule, Purkinje and inferior olivary neurons in lurcher chimeric mice. II. Granule cell death. Brain Res (1982) 1.02
Pituitary adenylate cyclase-activating polypeptide stimulates both c-fos gene expression and cell survival in rat cerebellar granule neurons through activation of the protein kinase A pathway. Neuroscience (1998) 1.01
Characterization of melanotropin-release-inhibiting factor (melanostatin) from frog brain: homology with human neuropeptide Y. Proc Natl Acad Sci U S A (1991) 0.97
Expression of pituitary adenylate cyclase activating polypeptide (PACAP) in the postnatal and adult rat cerebellar cortex. Neuroreport (1998) 0.96
Pituitary adenylate cyclase-activating peptide stimulates neurite growth in PC12 cells. Peptides (1995) 0.90
Novel forms of neuronal migration in the rat cerebellum. J Neurosci Res (1995) 0.90
Somatostatin receptors are expressed by immature cerebellar granule cells: evidence for a direct inhibitory effect of somatostatin on neuroblast activity. Proc Natl Acad Sci U S A (1992) 0.90
Numerical matching during cerebellar development: quantitative analysis of granule cell death in staggerer mouse chimeras. J Neurosci (1987) 0.87
Signals that go with the flow. Trends Neurosci (1999) 0.87
Ontogeny of pituitary adenylate cyclase-activating polypeptide (PACAP) and its binding sites in the rat brain. Neurosci Lett (1994) 0.86
Localization and characterization of PACAP receptors in the rat cerebellum during development: evidence for a stimulatory effect of PACAP on immature cerebellar granule cells. Neuroscience (1993) 0.86
Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates adenylyl cyclase and phospholipase C activity in rat cerebellar neuroblasts. J Neurochem (1995) 0.84
Chick/quail chimeras with partial cerebellar grafts: an analysis of the origin and migration of cerebellar cells. J Comp Neurol (1993) 0.83
TGF-beta-induced apoptosis of cerebellar granule neurons is prevented by depolarization. J Neurosci (1996) 0.82
Phenotypic development of neonatal rat chromaffin cells in response to adrenal growth factors and glucocorticoids: focus on pituitary adenylate cyclase activating polypeptide. Neurosci Lett (1995) 0.82
Filopodia and growth cones in the vertically migrating granule cells of the postnatal mouse cerebellum. Exp Brain Res (1997) 0.82
Ontogeny of pituitary adenylate cyclase-activating polypeptide (PACAP) receptors in the rat cerebellum: a quantitative autoradiographic study. Brain Res Dev Brain Res (1994) 0.81
Expression of pituitary adenylate cyclase activating polypeptide receptors in the early mouse embryo as assessed by reverse transcription polymerase chain reaction and in situ hybridisation. Neurosci Lett (1996) 0.80
Specific antibody recognition of rat pituitary adenylate cyclase activating polypeptide receptors. Endocrine (1997) 0.80
Pituitary adenylate cyclase-activating polypeptide activates different signal transducing mechanisms in cultured cerebellar granule cells. Neuroendocrinology (1995) 0.79
Cell migrations and establishment of neuronal connections in the developing brain: a study using the quail-chick chimera system. Prog Brain Res (1994) 0.79
Pituitary adenylate cyclase activating peptide and vasoactive intestinal polypeptide: differentiation effects on human neuroblastoma NB-OK-1 cells. Neurosci Lett (1993) 0.78
Plexin-neuropilin-1 complexes form functional semaphorin-3A receptors. Cell (1999) 3.84
Interferon response sequence potentiates activity of an enhancer in the promoter region of a mouse H-2 gene. Nature (1986) 3.73
Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol Rev (2000) 3.24
Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer (2005) 3.04
The long QT syndrome in children. An international study of 287 patients. Circulation (1993) 2.31
Low bone mineral density and peripheral blood monocyte activation profile in calcium stone formers with idiopathic hypercalciuria. J Clin Endocrinol Metab (1997) 2.30
Predictive factors for spontaneous closure of atrial septal defects diagnosed in the first 3 months of life. J Am Coll Cardiol (1993) 2.27
Structure and in vitro transcription of a glycine tRNA gene from Bombyx mori. EMBO J (1984) 2.27
Inactivation of Rho signaling pathway promotes CNS axon regeneration. J Neurosci (1999) 2.13
Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord. Proc Natl Acad Sci U S A (1998) 2.12
Cyclosporine bone remodeling effect prevents steroid osteopenia after kidney transplantation. Kidney Int (2000) 1.99
Can ethnic differences in men's preferences for women's body shapes contribute to ethnic differences in female adiposity? Obes Res (1993) 1.97
hCGRP8-37, a calcitonin gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in brain and periphery. J Pharmacol Exp Ther (1990) 1.60
The factorial decomposition of the Mahalanobis distances in habitat selection studies. Ecology (2008) 1.42
Structure-activity profile of calcitonin gene-related peptide in peripheral and brain tissues. Evidence for receptor multiplicity. J Pharmacol Exp Ther (1989) 1.42
Neurosteroids: expression of steroidogenic enzymes and regulation of steroid biosynthesis in the central nervous system. Pharmacol Rev (1999) 1.40
Calcitriol and calcium carbonate therapy in early chronic renal failure. Nephrol Dial Transplant (1995) 1.40
Postoperative evaluation after end-to-end subclavian-left coronary artery anastomosis in anomalous left coronary artery. J Thorac Cardiovasc Surg (1990) 1.39
[Factors in the progression of renal insufficiency during the 2 years preceding the use of dialysis]. Nephrologie (1999) 1.39
Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues. Prog Neurobiol (1992) 1.33
Cloning, sequence analysis and tissue distribution of the mouse and rat urotensin II precursors. FEBS Lett (1999) 1.32
Paracellin-1 is critical for magnesium and calcium reabsorption in the human thick ascending limb of Henle. Kidney Int (2001) 1.31
Monoclonal antibodies to rabbit progesterone receptor: crossreaction with other mammalian progesterone receptors. Proc Natl Acad Sci U S A (1983) 1.29
Effects of endothelin-1 on vascular permeability in the conscious rat: interactions with platelet-activating factor. Br J Pharmacol (1991) 1.27
Diet, vitamin D and vertebral mineral density in hypercalciuric calcium stone formers. Kidney Int (1991) 1.27
Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition. Br J Cancer (2011) 1.27
Adaptation of iso-tRNA concentration to mRNA codon frequency in the eukaryote cell. Biochimie (1979) 1.25
Randomised controlled trial of enalapril and beta blockers in non-diabetic chronic renal failure. BMJ (1994) 1.24
Pulmonary clearance of circulating endothelin-1 in dogs in vivo: exclusive role of ETB receptors. J Appl Physiol (1985) (1996) 1.21
One-step immunoaffinity purification of active progesterone receptor. Further evidence in favor of the existence of a single steroid binding subunit. Biochemistry (1985) 1.19
Synthesis, biological activity and conformational analysis of cyclic GRF analogs. Int J Pept Protein Res (1988) 1.18
Stable multicopy vectors for high-level secretion of recombinant human serum albumin by Kluyveromyces yeasts. Biotechnology (N Y) (1991) 1.18
Behaviours in trematode cercariae that enhance parasite transmission: patterns and processes. Parasitology (1994) 1.16
PACAP protects cerebellar granule neurons against oxidative stress-induced apoptosis. Eur J Neurosci (2002) 1.16
The S. Cerevisiae HAP complex, a key regulator of mitochondrial function, coordinates nuclear and mitochondrial gene expression. Comp Funct Genomics (2003) 1.16
Co-localization of vasoactive intestinal peptide (VIP) and enkephalins in chromaffin cells of the adrenal gland of amphibia. Stimulation of corticosteroid production by VIP. Life Sci (1983) 1.14
A search for specific and common susceptibility loci for schizophrenia and bipolar disorder: a linkage study in 13 target chromosomes. Mol Psychiatry (2001) 1.13
Presynaptic inhibition by neuropeptide Y in rat hippocampal slice in vitro is mediated by a Y2 receptor. Br J Pharmacol (1991) 1.13
Lack of histological evidence of vitamin D abnormality in the bones of anephric patients. Clin Sci (1973) 1.11
High-level secretion of correctly processed recombinant human interleukin-1 beta in Kluyveromyces lactis. Gene (1991) 1.10
Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on corticotropin-releasing hormone (CRH) gene expression in the rat hypothalamic paraventricular nucleus. Brain Res (1997) 1.10
Policy decisions on endocrine disruptors should be based on science across disciplines: a response to Dietrich et al. Endocrinology (2013) 1.08
Comment on "Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake". Science (2007) 1.08
Androgens induce expression of SPAK, a STE20/SPS1-related kinase, in LNCaP human prostate cancer cells. Mol Cell Endocrinol (2001) 1.07
Comparative characterization and autoradiographic distribution of neuropeptide Y receptor subtypes in the rat brain. J Neurosci (1993) 1.07
Biosynthesis of neurosteroids and regulation of their synthesis. Int Rev Neurobiol (2001) 1.06
Pituitary adenylate cyclase-activating polypeptide promotes cell survival and neurite outgrowth in rat cerebellar neuroblasts. Neuroscience (1997) 1.06
Converting enzyme inhibitor or AT1-receptor blocker for decreasing long-term mortality in patients with stroke history and renal dysfunction? Stroke (2003) 1.06
Endothelin-1 enhances neutrophil adhesion to human coronary artery endothelial cells: role of ET(A) receptors and platelet-activating factor. Br J Pharmacol (1999) 1.05
Inhibition of gastric secretion by omeprazole and efficiency of calcium carbonate on the control of hyperphosphatemia in patients on chronic hemodialysis. Artif Organs (1998) 1.04
Production of alginate beads by emulsification/internal gelation. I. Methodology. Appl Microbiol Biotechnol (1992) 1.04
Management of fetal tachyarrhythmia based on superior vena cava/aorta Doppler flow recordings. Heart (2003) 1.03
[Overdosage of metoclopramide in child. Apropos of 9 clinical cases]. Pediatrie (1970) 1.03
Discovery and evolutionary history of gonadotrophin-inhibitory hormone and kisspeptin: new key neuropeptides controlling reproduction. J Neuroendocrinol (2010) 1.02
Characterization of CGRP1 and CGRP2 receptor subtypes. Ann N Y Acad Sci (1992) 1.02
Nonadrenergic and noncholinergic arterial dilatation and venoconstriction are mediated by calcitonin gene-related peptide1 and neurokinin-1 receptors, respectively, in the mesenteric vasculature of the rat after perivascular nerve stimulation. J Pharmacol Exp Ther (1992) 1.01
Project Medishare: a volunteer program in international health at the University of Miami. Acad Med (2000) 1.01
Melanocortin-3 receptor mRNA expression in pro-opiomelanocortin neurones of the rat arcuate nucleus. J Neuroendocrinol (2000) 1.01
Characterization of ETB receptors mediating contractions induced by endothelin-1 or IRL 1620 in guinea-pig isolated airways: effects of BQ-123, FR139317 or PD 145065. Br J Pharmacol (1994) 1.01
Oral contraceptives, reproductive history and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition. Br J Cancer (2010) 1.01
Pituitary adenylate cyclase-activating polypeptide stimulates both c-fos gene expression and cell survival in rat cerebellar granule neurons through activation of the protein kinase A pathway. Neuroscience (1998) 1.01
Isolation and primary structure of urotensin II from the brain of a tetrapod, the frog Rana ridibunda. Biochem Biophys Res Commun (1992) 1.01
Comparative affinities and antagonistic potencies of various human calcitonin gene-related peptide fragments on calcitonin gene-related peptide receptors in brain and periphery. J Pharmacol Exp Ther (1991) 1.00
[Collapsing glomerulopathy and cytomegalovirus, what are the links?]. Presse Med (2000) 1.00
Metformin-associated lactic acidosis in diabetic patients with acute renal failure. A critical analysis of its pathogenesis and prognosis. Nephrol Dial Transplant (1994) 0.99
[Metoclopramide poisoning in children]. Nouv Presse Med (1972) 0.99
Potent and selective tools to investigate neuropeptide Y receptors in the central and peripheral nervous systems: BIB03304 (Y1) and CGP71683A (Y5). Can J Physiol Pharmacol (2000) 0.99
Immunocytochemical localization of the endogenous benzodiazepine ligand octadecaneuropeptide (ODN) in the rat brain. Neuropeptides (1990) 0.99
Ketodiet, physiological calcium intake and native vitamin D improve renal osteodystrophy. Kidney Int (1992) 0.98
Serotonin-induced stimulation of cortisol secretion from human adrenocortical tissue is mediated through activation of a serotonin4 receptor subtype. Neuroscience (1992) 0.98
Myxoedema coma: response of thyroid hormones with oral and intravenous high-dose L-thyroxine treatment. Intensive Care Med (1991) 0.97
Secretin as a neurohypophysial factor regulating body water homeostasis. Proc Natl Acad Sci U S A (2009) 0.97
[Letter: Neonatal septicemia and meningitis caused by Levinea malonatica]. Nouv Presse Med (1975) 0.97
Endothelin-1 enhances vascular permeability in the rat heart through the ETA receptor. Eur J Pharmacol (1992) 0.97
Characterization of melanotropin-release-inhibiting factor (melanostatin) from frog brain: homology with human neuropeptide Y. Proc Natl Acad Sci U S A (1991) 0.97
Characterization of neuropeptide Y binding sites in rat brain membrane preparations using [125I][Leu31,Pro34]peptide YY and [125I]peptide YY3-36 as selective Y1 and Y2 radioligands. J Pharmacol Exp Ther (1995) 0.97
A new locus on chromosome 12p13.3 for pseudohypoaldosteronism type II, an autosomal dominant form of hypertension. Am J Hum Genet (2000) 0.97
Acute pro-inflammatory actions of endothelin-1 in the guinea-pig lung: involvement of ETA and ETB receptors. Br J Pharmacol (1995) 0.96
Pituitary adenylate cyclase-activating polypeptide: focus on structure-activity relationships of a neuroprotective Peptide. Curr Med Chem (2009) 0.96
Orthodontic considerations in the treatment of maxillary impacted canines. Am J Orthod (1982) 0.96
Stimulation of the sympathetic perimesenteric arterial nerves releases neuropeptide Y potentiating the vasomotor activity of noradrenaline: involvement of neuropeptide Y-Y1 receptors. J Neurochem (1997) 0.96
Regulation of proopiomelanocortin gene expression by neuropeptide Y in the rat arcuate nucleus. Brain Res (1995) 0.95
Roles of corticotropin-releasing factor, neuropeptide Y and corticosterone in the regulation of food intake in Xenopus laevis. J Neuroendocrinol (2004) 0.95
Immunocytochemical localization and biological activity of 3 beta-hydroxysteroid dehydrogenase in the central nervous system of the frog. J Neurosci (1994) 0.95
Electrocardiographic depolarization and repolarization: long-term after Kawasaki disease. Pediatr Cardiol (2002) 0.95
The octadecaneuropeptide [diazepam-binding inhibitor (33-50)] exerts potent anorexigenic effects in rodents. Eur J Pharmacol (2001) 0.95